Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kanuni Sultan Suleyman Training and Research Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators are planning to determine the effect of the timing of oxytocin administration on the amount of blood loss, necessity for additional medical or surgical interventions.
The investigators are studying the effects of the timing of intramuscular oxytocin administration in the third stage of labour. The investigators are measuring the postpartum blood loss: quantitatively in the postpartum 1st hour and indirectly by the decrease in the hemoglobin-haematocrit levels in the postpartum 24th hour. The investigators are monitoring the length of the third stage of labour, and the need for extra uterotonics and/or surgical interventions.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control Group | Active Comparator | Oxytocin 10IU im was administered after placental delivery |
|
| Study Group | Experimental | Oxytocin 10IU im was administered after the anterior shoulder could be seen. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oxytocin | Drug | Oxytocin 10IU Administered intramuscularly. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Postpartum blood loss | Quantitative collection of blood loss. | Participants will be followed for the duration of hospital stay, an expected average of 24 hour |
| Postpartum blood loss >500cc | Number of participants whose blood loss is higher than 500cc. | Participants will be followed for the duration of hospital stay, an expected average of 24 hour |
| Measure | Description | Time Frame |
|---|---|---|
| Need for additional uterotonics | Additional uterotonics (Oxytocin 10IU; Cytotec tb Rectal and/or vaginal) were administered if postpartum blood loss >500ml OR uterine atony was observed OR sudden excessive hemorrhage was encountered. | Participants will be followed for the duration of hospital stay, an expected average of 24 hour |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dogukan Yildirim, MD | Contact | +905063284383 | dogukanyildirim@yahoo.com | |
| Eser S Ozyurek, MD | Contact | +905309322345 | eozyurek@yahoo.com |
| Name | Affiliation | Role |
|---|---|---|
| Burak Ozkose, MD | Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul | Study Chair |
| Dogukan Yildirim, MD | Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kanuni Sultan Suleyman Teaching and Research Hospital | Recruiting | Istanbul | 34303 | Turkey (Türkiye) |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 25108586 | Background | Oguz Orhan E, Dilbaz B, Aksakal SE, Altinbas S, Erkaya S. Prospective randomized trial of oxytocin administration for active management of the third stage of labor. Int J Gynaecol Obstet. 2014 Nov;127(2):175-9. doi: 10.1016/j.ijgo.2014.05.022. Epub 2014 Jul 17. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006473 | Postpartum Hemorrhage |
| ID | Term |
|---|---|
| D007744 | Obstetric Labor Complications |
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010121 | Oxytocin |
| ID | Term |
|---|---|
| D010909 | Pituitary Hormones, Posterior |
| D010907 | Pituitary Hormones |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Postpartum transfusion |
| Participants will be followed for the duration of hospital stay, an expected average of 24 hour. |
| Manual removal of the placenta. | At first hour after delivery of the fetus |
| Duration of the third stage of labour. | Participants will be followed for the duration of labor unit stay, an expected average of one hour |
| Drop in the hemoglobin and hematocrit levels | At the 24th hour,postpartum |
| Eser S Ozyurek, MD | Bagcilar Training and Research Hospital | Study Chair |
| Batuhan Ustun, MD | Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul | Study Chair |
| D011644 | Puerperal Disorders |
| D014592 | Uterine Hemorrhage |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D006730 |
| Hormones, Hormone Substitutes, and Hormone Antagonists |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |